Skip to main content
TipRanks
Go Ultimate75% OFF

Paradigm Biopharmaceuticals (PAR) Ratios

46 Followers

Paradigm Biopharmaceuticals Ratios

AU:PAR's free cash flow for Q4 2026 was AU$0.00. For the 2026 fiscal year, AU:PAR's free cash flow was increased by AU$24.04M and operating cash flow was AU$-24.04M. See a summary of the company’s cash flow.

Financial ratios
RatiosJun 26Jun 25Jun 24Jun 23Jun 22
Liquidity Ratios
Current Ratio1.107.467.224.896.02
Quick Ratio1.107.467.224.896.02
Cash Ratio0.585.205.304.325.07
Solvency Ratio-2.07-5.53-16.32-3.86-4.66
Operating Cash Flow Ratio-1.64-4.95-19.63-3.46-4.11
Short-Term Operating Cash Flow Coverage-6.110.00-541.23-430.46-217.96
Net Current Asset ValueAU$ 2.07MAU$ 20.74MAU$ 20.67MAU$ 50.39MAU$ 38.79M
Leverage Ratios
Debt-to-Assets Ratio0.250.000.010.010.01
Debt-to-Equity Ratio2.160.000.010.010.01
Debt-to-Capital Ratio0.680.000.010.010.01
Long-Term Debt-to-Capital Ratio0.000.000.000.000.00
Financial Leverage Ratio8.801.161.151.251.20
Debt Service Coverage Ratio-5.55-2642.23-429.99-428.55-221.41
Interest Coverage Ratio-24.83-3231.60-4536.74-3607.21-1641.85
Debt to Market Cap0.120.000.000.000.00
Interest Debt Per Share0.030.000.000.000.00
Net Debt to EBITDA0.130.670.270.950.83
Profitability Margins
Gross Profit Margin-102.76%-38.17%86.34%-40.26%-81.45%
EBIT Margin-76246.47%-48535.61%-98306.99%-126039.35%-59305.26%
EBITDA Margin-76058.84%-48436.95%-98083.59%-126308.81%-59094.47%
Operating Profit Margin-76246.47%-43910.60%-99077.51%-126638.15%-59339.34%
Pretax Profit Margin-79790.11%-48549.19%-89138.30%-126073.57%-59340.60%
Net Profit Margin-70282.28%-36014.48%-89138.30%-111013.69%-49543.07%
Continuous Operations Profit Margin-70282.28%-36014.48%-89138.30%-111013.69%-49543.07%
Net Income Per EBT88.08%74.18%100.00%88.05%83.49%
EBT Per EBIT104.65%110.56%89.97%99.55%100.00%
Return on Assets (ROA)-184.36%-76.39%-214.14%-77.40%-77.43%
Return on Equity (ROE)-1623.03%-88.61%-246.38%-96.71%-92.76%
Return on Capital Employed (ROCE)-1538.54%-107.25%-271.29%-109.60%-109.69%
Return on Invested Capital (ROIC)-484.07%-79.54%-241.23%-96.14%-90.95%
Return on Tangible Assets-189.99%-77.70%-239.96%-80.95%-82.21%
Earnings Yield-92.26%-19.57%-68.96%-18.61%-17.48%
Efficiency Ratios
Receivables Turnover0.010.010.010.010.01
Payables Turnover0.010.030.000.000.02
Inventory Turnover0.000.000.000.000.00
Fixed Asset Turnover0.161.750.350.140.14
Asset Turnover0.000.000.000.000.00
Working Capital Turnover Ratio0.010.000.000.000.00
Cash Conversion Cycle20965.5430774.44-86373.12-182632.9012956.84
Days of Sales Outstanding59489.6344636.3628193.2353136.5530954.78
Days of Inventory Outstanding0.000.000.000.000.00
Days of Payables Outstanding38524.0913861.92114566.34235769.4517997.94
Operating Cycle59489.6344636.3628193.2353136.5530954.78
Cash Flow Ratios
Operating Cash Flow Per Share-0.12-0.05-0.22-0.16-0.13
Free Cash Flow Per Share-0.12-0.05-0.22-0.16-0.13
Dividend Paid and CapEx Coverage Ratio0.00-3198643.00-1.000.00-8051316.50
Capital Expenditure Coverage Ratio0.00-3198643.00-1.000.00-8051316.50
Operating Cash Flow Coverage Ratio-5.82-2916.34-275.54-132.25-52.22
Operating Cash Flow to Sales Ratio-545.06-306.85-1002.20-966.34-406.51
Free Cash Flow Yield-71.55%-16.67%-77.53%-16.20%-14.34%
Valuation Ratios
Price-to-Earnings (P/E) Ratio-1.10-5.11-1.45-5.37-5.72
Price-to-Sales (P/S) Ratio761.771840.421292.595965.352834.21
Price-to-Book (P/B) Ratio17.594.533.575.205.31
Price-to-Free Cash Flow (P/FCF) Ratio-1.40-6.00-1.29-6.17-6.97
Price-to-Operating Cash Flow Ratio-1.40-6.00-1.29-6.17-6.97
Price-to-Earnings Growth (PEG) Ratio-0.010.07-0.13-0.430.00
Enterprise Value Multiple-0.87-3.13-1.05-3.77-3.96
Enterprise Value53.19M79.11M67.47M222.95M185.48M
EV to EBITDA-0.87-3.13-1.05-3.77-3.96
EV to Sales663.661517.851025.394767.932341.21
EV to Free Cash Flow-1.22-4.95-1.02-4.93-5.76
EV to Operating Cash Flow-1.22-4.95-1.02-4.93-5.76
Tangible Book Value Per Share0.010.070.070.180.16
Shareholders’ Equity Per Share0.010.070.080.190.18
Tax and Other Ratios
Effective Tax Rate0.120.260.100.120.17
Revenue Per Share0.000.000.000.000.00
Net Income Per Share-0.15-0.06-0.20-0.18-0.16
Tax Burden0.880.741.000.880.83
Interest Burden1.051.000.911.001.00
Research & Development to Revenue672.69340.39886.531126.58492.43
SG&A to Revenue88.7498.3394.47140.39100.15
Stock-Based Compensation to Revenue0.001.940.0020.0341.28
Income Quality0.780.851.120.870.82

Currency in AUD